Search results for "COPD"
Testing CRP level safely reduced antibiotic use in patients with COPD exacerbation
In patients with chronic obstructive pulmonary disease (COPD) exacerbations, point-of-care testing of C-reactive protein (CRP) level decreased antibiotic use without affecting clinical outcomes, a randomized controlled trial found.
https://immattersacp.org/weekly/archives/2019/07/16/1.htm
16 Jul 2019
MKSAP Quiz: Posthospital evaluation for severe COPD
A 64-year-old woman is evaluated during a posthospital visit for severe COPD with an FEV1 of 30% of predicted. She has been admitted three times during the last year with acute exacerbations. Following physical and pulmonary exams, what is the most appropriate treatment to reduce this patient's COPD exacerbations?
https://immattersacp.org/weekly/archives/2019/08/20/3.htm
20 Aug 2019
New model found to help predict 20-year risk of COPD
Prediction of future lung function could let clinicians identify those at high risk for chronic obstructive pulmonary disease (COPD), but the trajectory of lung function decline varies greatly among individuals, the authors noted.
https://immattersacp.org/weekly/archives/2019/10/01/4.htm
1 Oct 2019
Metoprolol not effective for reducing time to COPD exacerbation
A randomized placebo-controlled trial, which was stopped early due to safety and futility concerns, found no significant between-group difference in median time to first exacerbation of chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2019/10/29/4.htm
29 Oct 2019
MKSAP Quiz: 1-week history of chest pressure
A 35-year-old woman is evaluated for a 4-month history of exertional dyspnea and a 1-week history of chest pressure. She has no sputum production, cough, or wheezes. She has never smoked. Following a physical examination, laboratory studies, electrocardiogram, and chest radiograph, what is the most appropriate initial test?
https://immattersacp.org/weekly/archives/2020/03/17/3.htm
17 Mar 2020
Clinical practice guideline released on pharmacologic management of COPD
The American Thoracic Society strongly recommended LABA/LAMA combination therapy over monotherapy with either agent in patients with chronic obstructive pulmonary disease (COPD) and dyspnea or exercise intolerance, among other guidance.
https://immattersacp.org/weekly/archives/2020/04/21/4.htm
21 Apr 2020
Drive-in visits can fill the cracks of telemedicine's reach
Practices in rural areas are tackling the logistics of providing telemedicine to patients who are unable to access it on their own.
https://immattersacp.org/archives/2020/07/drive-in-visits-can-fill-the-cracks-of-telemedicines-reach.htm
1 Jul 2020
MKSAP Quiz: Peripheral 9-mm solid pulmonary nodule
A 72-year-old woman is evaluated during a routine visit. She has a 30-pack-year smoking history and quit 5 years ago. A screening low-dose chest CT scan shows a peripheral 9-mm solid pulmonary nodule in the left upper lobe and emphysema. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/08/25/4.htm
25 Aug 2020
Breathing easier from hospital to home
A substantial percentage of patients prescribed home oxygen at hospital discharge after an acute COPD exacerbation no longer meet the criteria two to three months later.
https://immattersacp.org/archives/2020/10/breathing-easier-from-hospital-to-home.htm
1 Oct 2020
Effects of pandemic on alcohol use, mental health, primary care, and hospitalizations
Recent studies found that the pandemic was associated with increases in alcohol use and internet searches for mental health issues. The rise of telemedicine meant fewer blood pressure and cholesterol evaluations, and hospitalizations for several non-COVID-19 conditions stayed below normal.
https://immattersacp.org/weekly/archives/2020/10/06/1.htm
6 Oct 2020